placebo+placebo

DRUG2 trials

Sponsors

Lise Tarnow, AstraZeneca

Conditions

Male Subjects With Type II Diabetes (T2DM)Type 2 Diabetes

Phase 1

Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)

CompletedNCT02935712

AstraZenecaMale Subjects With Type II Diabetes (T2DM)

Start: 2016-12-16End: 2018-01-08Updated: 2020-01-18

Phase 3

The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

CompletedNCT00699426

Lise TarnowType 2 Diabetes

Start: 2008-06-30End: 2009-06-30Updated: 2012-09-03